Return to Sports and Functional Outcomes after Autologous Platelet-Rich Fibrin Matrix (PRFM) and Debridement in Midportion Achilles Tendinopathy: A Case Series with 24-Month Follow-Up
- PMID: 37048830
- PMCID: PMC10094924
- DOI: 10.3390/jcm12072747
Return to Sports and Functional Outcomes after Autologous Platelet-Rich Fibrin Matrix (PRFM) and Debridement in Midportion Achilles Tendinopathy: A Case Series with 24-Month Follow-Up
Abstract
(1) Background: Achilles tendinopathy (AT) is characterized by load-induced tendon pain, stiffness, and functional impairment that may affect the tendon midportion or insertion. Platelet-rich fibrin matrix (PRFM) is a promising adjunctive therapy for AT. We analyzed 24-month pain and functional outcomes in a cohort of patients managed by tendon debridement and autologous PRFM application to determine whether the combined treatment ensured an early return to sports/work and satisfactory clinical outcomes and functional scores. (2) Methods: The 24-month outcomes of 32 sport-practicing patients with chronic midportion AT treated with debridement and autologous PRFM were evaluated in terms of time to return to sports/work. The AOFAS and VISA-A were computed preoperatively and at 6 and 24 months. Blazina scores were evaluated preoperatively and at 6 months; ankle range of motion was assessed at 1, 6, 12, 24 months; and patient satisfaction was assessed at 24 months. (3) Results: Altogether, all patients had resumed their sport(s) activity, at the same or higher level, after 25.41 days (±5.37). Regarding work, all patients were able to return to their jobs after 16.41 days (±2.43). Ankle dorsiflexion and plantarflexion increased significantly: the AOFAS rose from 54.56 (±6.47) to 97.06 (±4.06) and 98.88 (±2.21) at 6 and 12 months, respectively, and the mean VISA-A score rose from 69.16 (±7.35) preoperatively to 95.03 (±4.67) and 97.28 (±2.43) at 6 and 12 months, respectively, after treatment. There were no complications. Most (90.62%) patients were very satisfied. (4) Conclusions: In symptomatic midportion AT, surgical debridement and autologous PRFM ensured a fast return to sports/work (4 weeks), significantly improving AOFAS and VISA-A and Blazina scores already at 6 months and providing excellent clinical outcomes at 24 months.
Keywords: Achilles tendon; athletes; autologous PRFM; return to sports; return to work; tendinopathy.
Conflict of interest statement
The authors declare no conflict of interest.
Figures





Similar articles
-
Surgical and Biological Treatment with a Platelet-Rich Fibrin Matrix for Patellar Tendinopathy: Clinical Outcomes and Return to Sport at 2-Year Follow-Up.J Pers Med. 2024 May 25;14(6):567. doi: 10.3390/jpm14060567. J Pers Med. 2024. PMID: 38929787 Free PMC article.
-
Functional outcomes and return to sports after surgical treatment of insertional Achilles tendinopathy: Surgical approach tailored to the degree of tendon involvement.Orthop Traumatol Surg Res. 2018 Sep;104(5):719-723. doi: 10.1016/j.otsr.2018.05.003. Epub 2018 May 28. Orthop Traumatol Surg Res. 2018. PMID: 29852319
-
Effect of Platelet-Rich Plasma Injection vs Sham Injection on Tendon Dysfunction in Patients With Chronic Midportion Achilles Tendinopathy: A Randomized Clinical Trial.JAMA. 2021 Jul 13;326(2):137-144. doi: 10.1001/jama.2021.6986. JAMA. 2021. PMID: 34255009 Free PMC article. Clinical Trial.
-
[Midportion Achilles tendinopathy].Unfallchirurg. 2017 Dec;120(12):1038-1043. doi: 10.1007/s00113-017-0411-5. Unfallchirurg. 2017. PMID: 28921035 Review. German.
-
The effect of platelet-rich plasma injection on chronic Achilles tendinopathy and acute Achilles tendon rupture.Platelets. 2022 Apr 3;33(3):339-349. doi: 10.1080/09537104.2021.1961712. Epub 2021 Aug 4. Platelets. 2022. PMID: 34346853 Review.
Cited by
-
Surgical and Biological Treatment with a Platelet-Rich Fibrin Matrix for Patellar Tendinopathy: Clinical Outcomes and Return to Sport at 2-Year Follow-Up.J Pers Med. 2024 May 25;14(6):567. doi: 10.3390/jpm14060567. J Pers Med. 2024. PMID: 38929787 Free PMC article.
References
LinkOut - more resources
Full Text Sources
Miscellaneous